Laura Niskanen
Clinical Lecturer
Institute of Clinical Medicine, School of Medicine, Faculty of Health Sciences
Publications
4/4 items-
Combined gene therapy using AdsVEGFR2 and AdsTie2 with chemotherapy reduces the growth of human ovarian cancer and formation of ascites in mice
Tuppurainen L, Sallinen H, Karvonen A, Valkonen E, Laakso H, Liimatainen T, Hytönen E, Hämäläinen K, Kosma V-M, Anttila M, Ylä-Herttuala S. 2017. International journal of gynecological cancer. 27: 879-886 A1 Journal article (refereed), original research -
Gene Therapy for Ovarian Cancer : Antiangiogenic and Imaging Study
Tuppurainen Laura. 2017. Publications of the University of Eastern Finland. Dissertations in Health Sciences G5 Doctoral dissertation (article) -
Functional MRI Measurements to Predict Early Adenoviral Gene Therapy Response in Ovarian Cancer Mouse Model
Tuppurainen L, Sallinen H, Hakkarainen H, Liimatainen T, Hassan M, Ylä-Herttuala E, Anttila M, Hämäläinen K, Veli-Matti Kosma, Heinonen S, Alitalo K, Ylä-Herttuala S. 2013. Journal of genetic syndromes & gene therapy. 4: x-x A1 Journal article (refereed), original research -
Preclinical Safety, Toxicology, and Biodistribution Study of Adenoviral Gene Therapy with sVEGFR-2 and sVEGFR-3 Combined with Chemotherapy for Ovarian Cancer
Tuppurainen L, Sallinen H, Kokki E, Koponen J, Anttila M, Pulkkinen K, Heikura T, Toivanen P, Hämäläinen K, Kosma VM, Heinonen S, Alitalo K, Ylä-Herttuala S. 2013. Human gene therapy. clinical development. 24: 29-37 A1 Journal article (refereed), original research